Related topics: patients , children
The New England Journal of Medicine
hideThe New England Journal of Medicine (N Engl J Med or NEJM) is an English-language peer-reviewed medical journal published by the Massachusetts Medical Society. It is one of the most popular and widely-read peer-reviewed general medical journals in the world. It is also the oldest continuously published medical journal in the world.
For more information about The New England Journal of Medicine, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
News tagged with new england journal of medicine
Review: Reports on Pfizer drug studies misleading
Medicine & Health / Medications
Nov 11, 2009 |
3.8 / 5 (4) |
5
(AP) -- Analysis of a dozen published studies testing possible new uses for a Pfizer Inc. epilepsy drug found that reporting of the results was often fudged, indicating the medicine worked better than internal company documents ...
Study raises new questions about Merck pill Zetia
Medicine & Health / Medications
Nov 16, 2009 |
5 / 5 (3) |
1
(AP) -- A new study raises fresh concerns about Zetia and its cousin, Vytorin - drugs still taken by millions of Americans to lower cholesterol, despite questions raised last year about how well they work.
Early end to key study on benefits of niacin, a B vitamin, in keeping arteries open was premature
Nov 16, 2009 |
3.7 / 5 (3) |
0
Heart experts at Johns Hopkins are calling premature the early halt of a study by researchers at Walter Reed Army Medical Center and Washington Hospital Center on the benefits of combining extended-release niacin, a B vitamin, ...
Obesity will snuff out health benefits gained by smoking declines
Dec 02, 2009 |
5 / 5 (1) |
0
If obesity trends continue, the negative effect on the health of the U.S. population will overtake the benefits gained from declining smoking rates, according to a study by U-M and Harvard researchers published today in the ...
Trimming US health care spending will require new approaches, study finds
Nov 11, 2009 |
not rated yet |
0
Slowing the growth in U.S. health care spending will most likely require adoption of an array of strategies as well as an improved approach to moving promising strategies into widespread use, according to a new analysis by ...
Study: Kidney angioplasty brings risks, no benefit
Nov 11, 2009 |
not rated yet |
0
If you're among the hundreds of thousands of Americans with clogged kidney arteries, you might want to consider trying medicines before rushing into angioplasty to open them up. The pricey procedure is no more effective and ...
Drug therapy more cost-effective than angioplasty for diabetic patients with heart disease
Nov 17, 2009 |
not rated yet |
0
Many patients with diabetes should forego angioplasties for heart disease and just take medicine instead, according to a new National Institutes of Health study led by Stanford University School of Medicine researcher Mark ...
New Anti-Clotting Medication Not More Effective than Standard Care; Hint of Other Clinical Benefits
Medicine & Health / Medications
Nov 17, 2009 |
not rated yet |
0
(PhysOrg.com) -- Two large studies confirmed that an investigational, reversible anti-clotting medication failed to show greater effectiveness than clopidogrel or a placebo for patients undergoing a procedure to open blocked ...
Could Widely Used Rapid Influenza Tests Pose A Dangerous Public Health Risk?
Nov 17, 2009 |
not rated yet |
0
(PhysOrg.com) -- Rapid influenza diagnostic tests used in doctors' offices, hospitals and medical laboratories to detect H1N1 are virtually useless and could pose a significant danger to public health, according to a Loyola ...
New study measures HIV anti-retroviral regimens' safety and efficacy
Medicine & Health / HIV & AIDS
Dec 01, 2009 |
not rated yet |
0
A study in the New England Journal of Medicine released on World AIDS Day reports that viral failure, the point at which medication can no longer suppress the HIV infection, was twice as likely and happen ...
FDA-approved drug may slow beta cell destruction in type 1 diabetes patients
Dec 04, 2009 |
not rated yet |
0
New findings by UT Southwestern researchers suggest that a drug already used to treat autoimmune disorders might also help slow the destruction of insulin-producing cells in patients recently diagnosed with ...
New drug shows promise for those with clotting disorders
Dec 06, 2009 |
not rated yet |
0
A new study provides welcome news for patients with a common clotting disorder known as venous thromboembolism (VTE).
